The Elche-based Prospera Biotech rolls out a skin care cream to ease excessive sweating and support cancer patients
Excessive sweating can be uncomfortable and disruptive, especially when heat, stress, or illness amplify it. Conventional options range from iontophoresis and botulinum toxin injections to aluminum-based antiperspirants. The latter block sweat pores by clogging the outer skin layer, reducing moisture output. In recent years, researchers have explored complementary approaches that target the nervous system to lessen sweat production and ease related symptoms.
From the outset, researchers from Miguel Hernandez University and its biotechnology researchers have been exploring new avenues. Their work focuses on neural pathways in the skin, aiming to temper the signals that drive sweat gland activity. This line of research has already yielded several formulations designed to improve sensitivity in skin affected by cancer therapies and other conditions.
In this ongoing program, a team led by Miguel Hernandez University’s Institute for Health Biotechnology Development and Innovation has undertaken molecular studies to identify how sweat becomes excessive when the body’s cooling needs are overwhelmed. The project centers on a formula that modulates eccrine gland activity through active neuromodulators, offering a potential noninvasive alternative to traditional deodorants.
The company states that these active ingredients interact with nerve terminals in the skin. On one side, they help moderate eccrine gland output; on the other, they raise the activation threshold for sweat responses. Dr. Marta García Escolano, director of Prospera Biotech, notes that independent testing indicates the novel cream can cut sweating on hands and underarms by about half, providing a welcome option for those seeking to reduce moisture without resorting to antiperspirants first.
The patented components trace back to molecules developed by the IDIBE-UMH Sensory Neurobiology research group, part of the University Institute for Research, Development and Innovation in Health Biotechnology affiliated with Miguel Hernandez University in Elche. For more than two decades, this team has studied skin nerve endings, their activation mechanisms, and how the nervous-sensory system contributes to skin balance.
The peripheral nervous system plays a critical role in how humans perceive and adapt to their surroundings. It governs essential responses such as pain and itching, and without its proper function daily life would be far more challenging. The research and development efforts at UMH aim to translate sensory neurobiology insights into practical health products for broader use.
To date, Prospera Biotech has introduced several neuromodulatory formulations for sensitive or atopic-prone skin, including Nocisens and Nocisens Intense for dermatitis, Nocisens Baby for diaper area concerns, and Oncapsisens, a cream designed to support skin around cancer treatments. The latest product, Ecrisens, targets excessive sweating and offers a new pathway for people seeking relief beyond standard deodorants. Observers highlight that these innovations combine scientific rigor with a practical goal: improving skin comfort in real-world conditions.
Prospera Biotech describes its approach as transforming sensory neurobiology research into everyday health solutions. The company emphasizes that its portfolio addresses a range of skin concerns by leveraging neuromodulatory principles. Independent experts consulted for the program suggest the results show real potential for reducing sweat-related discomfort while maintaining natural skin function. Attribution: source materials from Prospera Biotech and the IDIBE-UMH Sensory Neurobiology program.
In summary, the ongoing collaboration between Miguel Hernandez University and Prospera Biotech is pushing forward a line of skin-care products that target nerve pathways to regulate sweat production. The strategic goal is to provide effective, noninvasive options for people dealing with excessive sweating and to expand the availability of neuromodulatory formulations for diverse skin needs. This work continues to illustrate how advances in sensory biology can translate into practical, patient-centered solutions.